Lacosamide Vivanta

Lacosamide, the active ingredient in Lacosamide Vivanta, is an anti‑epileptic presented as an injection for intravenous use. It treats partial‑onset seizures and broader epilepsy syndromes in adult patients.\n\nGNH India supplies Lacosamide Vivanta as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.

Lacosamide is an anti‑epileptic drug used to manage seizure disorders.\n\n- Partial‑onset seizures: reduces the frequency of focal seizures when used as adjunct therapy.\n- Focal epilepsy: provides seizure control in patients whose seizures are not adequately managed by other agents.\n- Refractory epilepsy: serves as an additional option for adults with uncontrolled seizures despite existing treatment.

Adverse reactions may occur with intravenous lacosamide administration.\n\nCommon Side Effects:\n- Dizziness\n- Nausea\n- Headache\n- Fatigue\n\nSerious or Rare Side Effects:\n- Cardiac arrhythmia (e.g., PR‑interval prolongation)\n- Suicidal thoughts or behavior\n- Severe skin reactions such as Stevens‑Johnson syndrome

Lacosamide requires careful clinical assessment before use.\n\n- Renal impairment: monitor renal function and adjust therapy as needed.\n- Hepatic impairment: use with caution and observe liver enzymes.\n- Cardiac conduction disorders: obtain baseline ECG and monitor for PR‑interval changes.\n- Concomitant CNS depressants: anticipate increased sedation or respiratory depression.\n- Pregnancy: risk unknown; weigh potential benefits against possible fetal risks.\n- Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Lacosamide may interact with other medicines, requiring vigilance.\n\nMajor Interactions (Avoid):\n- Strong CYP3A4 inhibitors (e.g., ketoconazole): may increase lacosamide levels.\n- Strong CYP3A4 inducers (e.g., rifampicin): may reduce efficacy.\n- Other sodium‑channel blockers (e.g., carbamazepine): risk of additive cardiac effects.\n\nModerate Interactions (Monitor Closely):\n- Carbamazepine: may lower lacosamide concentrations.\n- Phenytoin: may alter seizure control.\n- Oral contraceptives: potential reduction in hormonal efficacy.